INVESTER I SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO MED ENDAVU: Køb Sichuan Kelun-Biotech Biopharmaceutical Co ($6990) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Sichuan Kelun-Biotech Biopharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative drugs for oncology and other serious diseases. The company is particularly active in antibody-drug conjugates (ADCs), where it is considered an early mover with extensive experience developing targeted therapies for prevalent and hard-to-treat cancers. Its pipeline and products are designed to address significant unmet medical needs in both domestic and international markets, with an emphasis on conditions affecting large and underserved patient populations. Operating within the healthcare and biotechnology sectors, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. integrates discovery, clinical development, and industrial-scale production capabilities, positioning itself as a specialized player in advanced biologics and oncology-focused therapeutics. Founded in 2016 and headquartered in China, the company today plays a growing role in the global biopharmaceutical landscape through its focus on clinically differentiated, novel treatments.